MiNK Therapeutics, Inc.·4

Jan 12, 10:48 AM ET

van Dijk Marcus Antonius 4

4 · MiNK Therapeutics, Inc. · Filed Jan 12, 2023

Insider Transaction Report

Form 4
Period: 2023-01-09
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2023-01-09$2.32/sh+51,628$119,77751,628 total
  • Tax Payment

    Common Stock

    2023-01-09$2.32/sh24,265$56,29527,363 total
Footnotes (3)
  • [F1]Reflects the executive's 2022 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.
  • [F2]$2.32 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 9, 2023, the stock issuance date.
  • [F3]Represents payment of tax liability by withholding shares of common stock incident to the vesting of stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION